These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23033232)

  • 21. Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model.
    Miki A; Ohtani H; Sawada Y
    J Clin Pharm Ther; 2011 Dec; 36(6):642-50. PubMed ID: 21143257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of rivaroxaban to the international normalized ratio when switching to warfarin for anticoagulation as determined by simulation studies.
    Siegmund HU; Burghaus R; Kubitza D; Coboeken K
    Br J Clin Pharmacol; 2015 Jun; 79(6):959-66. PubMed ID: 25510952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leflunomide and warfarin interaction: case report and review of the literature.
    Chonlahan J; Halloran MA; Hammonds A
    Pharmacotherapy; 2006 Jun; 26(6):868-71. PubMed ID: 16716139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children.
    Shaw K; Amstutz U; Hildebrand C; Rassekh SR; Hosking M; Neville K; Leeder JS; Hayden MR; Ross CJ; Carleton BC
    Pediatr Blood Cancer; 2014 Jun; 61(6):1055-62. PubMed ID: 24474498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brand name versus generic warfarin: a systematic review of the literature.
    Dentali F; Donadini MP; Clark N; Crowther MA; Garcia D; Hylek E; Witt DM; Ageno W;
    Pharmacotherapy; 2011 Apr; 31(4):386-93. PubMed ID: 21449627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential interaction between telithromycin and warfarin.
    Kolilekas L; Anagnostopoulos GK; Lampaditis I; Eleftheriadis I
    Ann Pharmacother; 2004 Sep; 38(9):1424-7. PubMed ID: 15280511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral anticoagulants. Pharmacologic issues for use in the elderly.
    Hylek EM
    Clin Geriatr Med; 2001 Feb; 17(1):1-13. PubMed ID: 11270124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug interactions with antiretrovirals and warfarin.
    Liedtke MD; Rathbun RC
    Expert Opin Drug Saf; 2010 Mar; 9(2):215-23. PubMed ID: 20095918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Further elucidation of pharmacokinetic interaction between diltiazem and warfarin.
    Stoysich AM; Lucas BD; Mohiuddin SM; Hilleman DE
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):56-60. PubMed ID: 8929747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of transdermal isopropyl alcohol on the international normalized ratio in five warfarin-treated patients.
    Pitcock JJ; Oluyemi OO; Pitcock MB
    Pharmacotherapy; 2013 Nov; 33(11):e333-6. PubMed ID: 23649958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychotropic drug metabolism in the cancer patient: clinical aspects of management of potential drug interactions.
    Kalash GR
    Psychooncology; 1998; 7(4):307-20. PubMed ID: 9741070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects.
    Moore KT; Byra W; Vaidyanathan S; Natarajan J; Ariyawansa J; Salih H; Turner KC
    Br J Clin Pharmacol; 2015 Jun; 79(6):907-17. PubMed ID: 25475601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient factors that influence warfarin dose response.
    White PJ
    J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial.
    Yuan CS; Wei G; Dey L; Karrison T; Nahlik L; Maleckar S; Kasza K; Ang-Lee M; Moss J
    Ann Intern Med; 2004 Jul; 141(1):23-7. PubMed ID: 15238367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.